Abstract: The invention relates to a process for the preparation of urea from ammonia and carbon dioxide, which preparation takes places wholy or partly with the application of a synthesis reactor, a condenser, a scrubber and a stripper, wherein an outlet of the stripper, through which a gas stream is discharged during operation, is functionally connected to the inlet of the condenser and to the inlet of the reactor and wherein an outlet of the condenser is functionally connected to an inlet of the scrubber and wherein the obtained reaction mixture is stripped in the stripper in countercurrent with one of the starting materials, wherein the gas stream coming from the top of the submerged condenser is subjected to an extra washing step before this gas stream is supplied to the high-pressure scrubber. The submerged condenser operating as such may be for example a submerged condenser of horizontal or vertical design of a falling-film high-pressure carbamate condenser transformed into a submerged condenser.
Abstract: Silanes of the formula Ra1R4-a-xSiLx??(I) where each R is identical or different and is a monovalent, optionally substituted hydrocarbon radical which is free of aliphatic carbon—carbon multiple bonds and has from 1 to 18 carbon atoms per radical, R1 is an optionally substituted 2-norbornyl radical, L is a leaving group, a is 1, 2 or 3 and x is 1 or 2, with the proviso that the sum of a+x?4, are useful for protecting functional groups of organic compounds (2) which have at least one functional group having an active hydrogen atom, preferably as a hydroxyl group —OH, a thiol groups —SH, an amine group —NH— or —NH2, a carboxyl group —COOH, or an amide group —CONH— or —CONH2.
Abstract: The compounds of formula 1, wherein R and R2 are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.
Type:
Grant
Filed:
June 13, 2003
Date of Patent:
April 19, 2005
Assignee:
Dompé S.p.A.
Inventors:
Riccardo Bertini, Cinzia Bizzarri, Vilma Sabbatini, Gianfranco Caselli, Marcello Allegretti, Maria Candida Cesta, Carmelo Gandolfi, Marco Mantovanini, Francesco Colotta, Stefano Porzio
Abstract: This invention relates to improved catalytic compositions suited for use in hydrogenation processes and to an improved process for hydrogenating organic compounds as in amination of alcohols or hydrogenation of nitrile and nitro groups to the amine using the catalyst. The catalytic composition is more particularly an improvement in nickel catalysts promoted with palladium carried on a support. The improvement resides in including a promoting effect of a metal M and/or its oxide, selected from Zn, Cd, Cu, and Ag, typically from about 0.01 to 10% by weight of the support.
Abstract: The use of mitochondrial KATP channel openers, particularly compounds of general formula (I), for the treatment or prevention of inflammation by inducing apoptosis of inflammatory cells.
Type:
Grant
Filed:
November 16, 2001
Date of Patent:
April 12, 2005
Assignee:
Orion Corporation
Inventors:
Heimo Haikala, Minja Hyttilä-Hopponen, Erkki Nissinen, Minna Ruotsalainen, Aino Pippuri, Kari Lönnberg
Abstract: Alkenylalkoxysilanes such as allyltrimethoxysilane can be made by reacting the corresponding monoalkenyldichlorosilane, i.e., allyldichlorosilane, with a monohydroxy alcohols, i.e., methyl alcohol. No catalyst is required and the reactions can be carried out at room temperature.
Type:
Grant
Filed:
October 11, 2002
Date of Patent:
April 12, 2005
Assignee:
Dow Corning Corporation
Inventors:
Binh Thanh Nguyen, John Patrick Cannady
Abstract: The invention relates to bis(alkylthio)carbenium salts of the formula I with the stated definitions for R1, R2, R3 and Y?, and to a process for the preparation thereof. The compounds according to the invention are advantageously suitable as electrophilic reagents for the transfer of fluorinated alkyl and acyl radicals onto nucleophilic compounds.
Type:
Grant
Filed:
February 11, 2002
Date of Patent:
April 5, 2005
Assignee:
Merck Patent GmbH
Inventors:
Peer Kirsch, Andreas Ruhl, Gerd-Volker Röschenthaler, Dmitrii Sevenard
Abstract: Provided is a bis(diphenylvinyl)arene compound having a reactive functional group on phenyl group, represented by below formula (1), wherein, Ar is an arylene group and has one or more substituents; R1-R22 each independently represent a hydrogen atom, a halogen atom, cyano group, nitro group, etc., and at least one of R1-R20 is a halogen atom, etc. The arene compound has sufficient solubility in an organic solvent and excellent reactivity.
Abstract: A method for the production of synthesis urea from liquid ammonia and gaseous carbon dioxide, comprising the step of feeding separate flows (6, 8) of liquid ammonia and gaseous carbon dioxide in continuous to a substantially vertical or horizontal column synthesis reactor (1), is distinguished in that the feed of liquid ammonia is split up into at least two consecutive sections (Z1-Z7) of said column.
Abstract: An organosiloxane polymer comprising recurring units of the general formula (1) and having a weight average molecular weight of 1,000-500,000 is novel. R1 to R4 are monovalent hydrocarbon groups, n is an integer of 1-2,000, X has a structure of the formula: and R5 is an acrylic functional organic group of the formula: wherein R? is H or methyl and R? is a divalent hydrocarbon group. A photo-curable resin composition comprising the organosiloxane polymer and a sensitizer can be cured with a wide wavelength range of light.
Abstract: A method for purifying melamine comprising impurities like ureido-melamine, oxotriazines, melam, melem, comprises the step of putting into contact at a temperature comprised between 340° C. and 410° C. and at a pressure comprised between 8 and 17 MPa a melamine melt with a bed of a catalyst thus obtaininig melamine with a purity of at least 99%.
Abstract: The present invention is directed to novel polymorphic Forms XI, XII, XIII, XIV, XV and XVI of sertraline hydrochloride, to processes for preparing them, methods of using them to treat disease, methods of using them to make other sertraline hydrochloride forms, and to pharmaceutical dosages containing the novel forms.
Type:
Grant
Filed:
September 13, 2002
Date of Patent:
February 22, 2005
Assignee:
Teva Pharmaceutical Industries Ltd.
Inventors:
Judith Aronhime, Marioara Mendelovici, Tamar Nidam, Claude Singer
Abstract: A compound having at least one H—Si group is reacted with an unsaturated aliphatic compound in the presence of a platinum catalyst and at least one organic additive component. The combination of platinum catalyst and additive component is one of: (i) a solution of a Pt(0) complex catalyst in a solvent, with at least one organic amide, or (ii) a solution of a Pt(0) complex catalyst in a solvent, with at least one organic amine, or (iii) a solution of a Pt(0) complex catalyst, in a solvent, with at least one organic nitrite.
Type:
Grant
Filed:
October 10, 2002
Date of Patent:
February 22, 2005
Assignee:
Degussa AG
Inventors:
Sabine Giessler, Helmut Mack, Dieter Barfurth
Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.
Type:
Grant
Filed:
September 18, 2002
Date of Patent:
February 15, 2005
Assignee:
Warner-Lambert Company
Inventors:
Garrett Stewart Hoge, II, Om Prakash Goel
Abstract: A process for preparing bisallylboranes of the formula (I) by reacting a diene with sodium borohydride in the presence of an oxidant: in an inert solvent, with the borane generated in situ reacting selectively with the diene to form the bis(allyl)borane of the formula (I) and the substituents R1 to R6 having the following meanings: R114 R6 are H, aryl or substituted or unsubstituted C1-C4-alkyl or two radicals R may be closed to form a cyclic system. As oxidant, it is possible to use, for example, alkyl halides or dialkyl sulfates. In a particularly preferred embodiment, the diene used is 2,5-dimethylhexa-2,4-diene (R1, R2, R5, R6=methyl, R3, R4=H).
Type:
Grant
Filed:
August 28, 2003
Date of Patent:
February 15, 2005
Assignee:
Clariant GmbH
Inventors:
Stefan Scherer, Alexei Kalinin, Victor Snieckus
Abstract: Process for the preparation of urea from ammonia and carbon dioxide in which all or part of the liquid ammonia needed for the process is supplied to the high-pressure scrubber in such a way that it is in direct contact with the other streams supplied to this scrubber. In particular in such a way that there is direct contact between the liquid ammonia and the off-gases transferred to the high-pressure scrubber from the urea synthesis reactor. More in particular in such a way that there is direct contact between the liquid ammonia and the off-gases transferred to the high-pressure scrubber from the urea reactor and with the carbamate stream, which is transferred from the low-pressure urea recovery section.
Type:
Grant
Filed:
November 1, 2001
Date of Patent:
February 15, 2005
Assignee:
DSM IP Assets B.V.
Inventors:
Andreas Johannes Biermans, Kees Jonckers
Abstract: The present invention provides a new process for the preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride, wherein this compound is prepared directly from the chloromethylalcohol. Importantly, the process of the present invention results in higher yields of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride without sacrificing its purity. The processes of the present invention can be used to prepare not only the 2S,3S-derivative, but also the 2R,3S-, 2S,2R- and the 2R,3R-derivatives.
Type:
Grant
Filed:
March 4, 2003
Date of Patent:
February 8, 2005
Assignee:
Aerojet Fine Chemicals LLC
Inventors:
Aslam A. Malik, Hasan Palandoken, Joy A. Stringer, Roland P. Carlson, John Leach, Thomas G. Archibald, Robert G. Miotke
Abstract: Optically impure tamsulosin including racemic tamsulosin can be resolved into optically pure (R)- or (S)-tamsulosin by the use of diastereomeric sulfonate salts of tamsulosin in a fractional crystallization technique. Racemic tamsulosin free base is a useful starting material for the resolution process and a method of obtaining the same in solid form, including two crystalline polymorphic forms, is also provided.
Type:
Grant
Filed:
July 31, 2002
Date of Patent:
December 28, 2004
Assignee:
Synthon BV
Inventors:
Hans J Hoorn, Theodorus H. A. Peters, Jaroslav Pis, Radim Scigel
Abstract: A process for the production of melamine by pyrolysis of urea in a high-pressure reactor having a vertical central pipe is provided. The melamine flows upwards into the reactor from below, mixes in the lower part of the reactor with a urea melt, and optionally NH3, introduced into the reactor from below, and emerges from the central pipe in the upper part of the central pipe. Part of the melamine formed flows downward in the annular space between the central pipe and reactor wall, and the remainder is expelled for further work-up. The off-gases are removed at the top of the reactor. A reactor for carrying out the process is also provided.
Type:
Grant
Filed:
October 7, 2003
Date of Patent:
November 9, 2004
Assignee:
Agrolinz Melamin GmbH
Inventors:
Hartmut Bucka, Gerhard Coufal, Ferdinand Koglgruber